2.9419
Precedente Chiudi:
$2.86
Aprire:
$2.96
Volume 24 ore:
324.85K
Relative Volume:
0.59
Capitalizzazione di mercato:
$109.97M
Reddito:
-
Utile/perdita netta:
-
Rapporto P/E:
-
EPS:
-
Flusso di cassa netto:
-
1 W Prestazione:
+9.76%
1M Prestazione:
+58.74%
6M Prestazione:
+99.50%
1 anno Prestazione:
+50.64%
Metagenomi Inc Stock (MGX) Company Profile
Nome
Metagenomi Inc
Settore
Industria
Telefono
(510) 871-4880
Indirizzo
5959 HORTON STREET, EMERYVILLE
Confronta MGX con altri titoli
Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
---|---|---|---|---|---|---|
![]()
MGX
Metagenomi Inc
|
2.93 | 107.34M | 0 | 0 | 0 | 0.00 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
407.07 | 104.55B | 11.39B | 3.64B | 3.50B | 13.99 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
472.04 | 60.36B | 2.46B | -319.09M | -52.09M | -2.4669 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
551.61 | 59.84B | 14.21B | 4.46B | 3.56B | 39.69 |
![]()
ARGX
Argen X Se Adr
|
809.47 | 49.07B | 3.06B | 1.28B | 447.35M | 19.67 |
![]()
ONC
Beone Medicines Ltd Adr
|
331.09 | 35.16B | 4.56B | -176.77M | 225.30M | -1.7177 |
Metagenomi Inc Stock (MGX) Upgrades & Downgrades
Data | Azione | Analista | Modifica della valutazione |
---|---|---|---|
2024-05-07 | Iniziato | H.C. Wainwright | Buy |
2024-05-02 | Downgrade | JP Morgan | Overweight → Neutral |
2024-03-05 | Iniziato | BMO Capital Markets | Outperform |
2024-03-05 | Iniziato | Chardan Capital Markets | Buy |
2024-03-05 | Iniziato | JP Morgan | Overweight |
2024-03-05 | Iniziato | Jefferies | Buy |
2024-03-05 | Iniziato | TD Cowen | Outperform |
2024-03-05 | Iniziato | Wells Fargo | Overweight |
Mostra tutto
Metagenomi Inc Borsa (MGX) Ultime notizie
Using Ichimoku Cloud for Metagenomi Inc. technicals2025 Geopolitical Influence & Free Technical Pattern Based Buy Signals - newser.com
Chart overlay techniques for tracking Metagenomi Inc.July 2025 Momentum & Community Consensus Picks - newser.com
Will Metagenomi Inc. stock go up soonJuly 2025 Trends & Low Risk Growth Stock Ideas - newser.com
Will Metagenomi Inc. stock see insider buyingBull Run & Safe Capital Growth Plans - newser.com
Metagenomi's (MGX) Sell (D-) Rating Reaffirmed at Weiss Ratings - MarketBeat
What candlestick patterns are forming on Metagenomi Inc.2025 Risk Factors & AI Forecasted Entry and Exit Points - newser.com
What recovery options are there for Metagenomi Inc.Market Rally & Long-Term Growth Stock Strategies - newser.com
Measuring Metagenomi Inc.’s beta against major indicesTrade Analysis Summary & Weekly Market Pulse Updates - newser.com
How Metagenomi Inc. stock performs in rate cut cyclesWeekly Trade Analysis & AI Enhanced Market Trend Forecasts - newser.com
Why Metagenomi Inc. stock could outperform in 20252025 Trading Volume Trends & Expert Approved Momentum Trade Ideas - newser.com
Custom watchlist performance reports with Metagenomi Inc.Quarterly Earnings Report & Safe Capital Growth Stock Tips - newser.com
Detecting support and resistance levels for Metagenomi Inc.July 2025 Weekly Recap & Weekly High Potential Alerts - newser.com
Best data tools to analyze Metagenomi Inc. stockEarnings Recap Summary & Community Supported Trade Ideas - newser.com
Why Metagenomi Inc. stock could be next big winner2025 Volume Leaders & Community Verified Watchlist Alerts - newser.com
Metagenomi (NASDAQ:MGX) versus SCYNEXIS (NASDAQ:SCYX) Head-To-Head Analysis - Defense World
What technical signals suggest for Metagenomi Inc. stockJuly 2025 Trade Ideas & Daily Risk Controlled Trade Plans - newser.com
Can you recover from losses in Metagenomi Inc.Market Movement Recap & Accurate Entry and Exit Point Alerts - newser.com
Metagenomi, Inc. Enters into A Non-Exclusive License Agreement with Acuitas Therapeutics, Inc - MarketScreener
Goldman Sachs Group Inc. Trims Stock Position in Metagenomi, Inc. $MGX - Defense World
Metagenomi Inc Azioni (MGX) Dati Finanziari
Non sono disponibili dati finanziari per Metagenomi Inc (MGX). Controlla altri titoli per ulteriori informazioni.
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):